(Press-News.org) Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press on July 26th in the journal Cell Reports. The findings reveal a potential biomarker that can be used to predict how these patients will respond to chemotherapy, as well as the patients' overall prognosis, paving the way for personalized treatment strategies.
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related death in men, and it is frequently treated with cisplatin. However, responses are often brief and ineffective because cancer cells become resistant to cisplatin-induced cell death. "We were interested in finding new genes, proteins, and pathways that would govern the response to cisplatin and might explain cisplatin resistance," says senior study author Guido Kroemer of INSERM—the French National Institute of Health and Medical Research.
To identify factors that affect whether cells die in response to cisplatin, Kroemer and his team performed a genome-wide screen in which they interfered with the expression of tens of thousands of genes in cells from patients with NSCLC. They identified 85 factors that modify drug responses, including pyridoxal kinase (PDXK), an enzyme that converts vitamin B6 precursors into their active form.
Treatment with a vitamin B6 precursor enhanced the anti-tumor effects of cisplatin in mouse models of lung cancer and promoted cisplatin-induced death in a variety of cancer cell lines, but only when PDXK was present. Moreover, NSCLC patients with high expression levels of PDXK had higher survival rates than those with low levels of the enzyme, regardless of whether they were being treated with cisplatin.
Together, the findings point to PDXK as an easy-to-monitor potential biomarker for predicting both the responses of NSCLC patients to cisplatin and their general outcomes. "Patients who have high levels of PDXK might benefit from combination therapies of cisplatin and vitamin B6," Kroemer says. "However, for those patients whose tumors express low levels of PDXK, new strategies of cancer treatment have to be developed."
###Galluzzi et al.: "Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer."
New biomarker for common lung cancer predicts responses to chemotherapy
2012-07-26
ELSE PRESS RELEASES FROM THIS DATE:
Methane measurements at low level flight
2012-07-26
A team of scientists from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association (AWI) and the GFZ German Research Centre for Geosciences has just completed an airborne measurement campaign that allowed for the first time to measure large-scale methane emissions from the extensive Arctic permafrost landscapes. The study area extended from Barrow, the northernmost settlement on the American mainland, across the entire North Slope of Alaska, to the Mackenzie Delta in the Northwest Territories of Canada. The airborne measurements (Airborne ...
Unprecedented accuracy in locating brain electrical activity with new device
2012-07-26
Researchers at Aalto University in Finland have developed the world's first device designed for mapping the human brain that combines whole-head magnetoencephalography (MEG) and magnetic resonance imaging (MRI) technology. MEG measures the electrical function and MRI visualizes the structure of the brain. The merging of these two technologies will produce unprecedented accuracy in locating brain electrical activity non-invasively.
We expect that the new technology will improve the accuracy of brain mapping of patients with epilepsy. It may also improve the diagnosis of ...
DNA damage in roofers due to PAH exposure – possible cancer link
2012-07-26
Roofers and road construction workers who use hot asphalt are exposed to high levels of polycyclic aromatic hydrocarbons (PAHs). A University of Colorado Cancer Center study published this week in the British Medical Journal Open shows that roofers have higher PAH blood-levels after a shift than before and that these high levels of PAHs are linked with increased rates of DNA damage, and potentially with higher cancer risk.
"We've known for some time that roofers and road workers have higher cancer rates than the general population, but we also know roofers have a higher ...
Deadly E. coli strain decoded
2012-07-26
EAST LANSING, Mich. — The secret to the deadly 2011 E. coli outbreak in Germany has been decoded, thanks to research conducted at Michigan State University.
The deadliest E. coli outbreak ever, which caused 54 deaths and sickened more than 3,800 people, was traced to a particularly virulent strain that researchers had never seen in an outbreak before. In the current issue of the academic journal PLoS ONE, a team of researchers led by Shannon Manning, MSU molecular biologist and epidemiologist, suggests a way to potentially tame the killer bacteria.
The strain, E. coli ...
'Basarab' surname may not indicate direct relation to Vlad the Impaler
2012-07-26
WASHINGTON—A study by the Genographic Project has shown that not all individuals carrying the Romanian "Basarab" surname, the first dynasty of Wallachian kings that included the real-life Dracula, can be direct biological descendants of the Basarab dynasty.
The Basarab dynasty ruled Wallachia, the historical and geographical southern region of present-day Romania, for almost three centuries (1330-1601) and had among its members Vlad III the Impaler, commonly known as Dracula. The ethnic origin of the Basarab family has long been a dispute among historians, with both an ...
Should high-dose interleukin-2 continue to be the treatment of choice for metastatic melanoma?
2012-07-26
New Rochelle, NY, July 26, 2012— Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc. (http://www.liebertpub.com), explores whether or not this regimen is still the most effective. The article is available free online at the Cancer Biotherapy and Radiopharmaceuticals website (http://www.liebertpub.com/cbr).
In the article "Should High-Dose Interleukin-2 ...
Toddlers object when people break the rules
2012-07-26
We all know that, for the most part, it's wrong to kill other people, it's inappropriate to wear jeans to bed, and we shouldn't ignore people when they are talking to us. We know these things because we're bonded to others through social norms – we tend to do things the same way people around us do them and, most importantly, the way in which they expect us to do them.
Social norms act as the glue that helps to govern social institutions and hold humans societies together, but how do we acquire these norms in the first place?
In a new article published in the August ...
Robotic surgery outcomes data presented at head and neck cancer annual meeting
2012-07-26
Predictors of disease severity in human papillomavirus-derived head and neck cancer, tobacco use, and the dramatic benefits of robotic surgery in people with head and neck cancer are among landmark research presented by Mount Sinai School of Medicine at the Eighth International Conference on Head and Neck Cancer. The meeting took place from July 21-25, 2012 in Toronto.
Highlights of Mount Sinai research at the American Head and Neck Society conference:
Transoral Robotic Surgery Shows Significant Promise in Hard-to-Treat Smokers with Head and Neck Cancer
In a retrospective ...
Hoard of Crusader gold found in ruins
2012-07-26
A team of researchers from Tel Aviv University has uncovered a hoard of real-life buried treasure at the Crusader castle of Arsur (also known as Apollonia), a stronghold located between the ancient ports of Jaffa and Caesarea, in use from 1241 to its destruction in 1265. The hoard, comprised of 108 gold coins, mostly dinars dated to the Fatimid Period (ca. 900 to 1100 AD), was discovered in a pot by a university student. The coins bear the names of sultans and blessings, and usually include a date and a mint name that indicates where a coin was struck.
This fascinating ...
VCU medical team recommends preventive antibiotic for COPD sufferers
2012-07-26
RICHMOND, Va. (July 26, 2012) – Patients suffering from the chronic lung condition COPD, which is the third-leading cause of death and disability in the United States, may benefit greatly from a three-times-a-week dose of an antibiotic, according to a study by Virginia Commonwealth University physicians published in today's issue of the New England Journal of Medicine.
Approximately 24 million Americans suffer from COPD, or chronic obstructive pulmonary disease, which creates recurrent, acute episodes of severe shortness of breath, cough and sputum production. Every ...